Interaction of Some Amino-Nitrile Derivatives with Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) Using a Theoretical Model
Drug Research · 01.07.2023 · 73 (06) · 355-364
DOI: 10.1055/a-2062-3571 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Research, erschienen am 01.07.2023. Verfasst von Lauro Figueroa-Valverde und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmaco-Chemistry, Faculty of Chemical Biological Sciences, University Autonomous of Campeche, Campeche, Camp., México. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor Receptor-1, Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Background
Some studies indicate that the angiogenesis process is related to vascular endothelial growth factor, which can interact with endothelial cell surface receptors (VEGF-R1, VEGF-R2, and VEGF-R3); this biochemical process and other factors result in the promotion and growth of new blood vessels under normal conditions. However, some studies indicate that this phenomenon could also occur in cancer cells. It is important to mention that some amino derivatives have been prepared as VEGF-R1 inhibitors; however, their interaction with VEGF-R1 is not clear, perhaps due to different experimental approaches or differences in their chemical structure.
Objective
The aim of this study was to evaluate the theoretical interaction of several amino-nitrile derivatives (Compounds 1 to 38) with VEGF-R1.
Methods
The theoretical interaction of amino-nitrile derivatives with VEGF-R1 was carried out using the 3hng protein as the theoretical model. In addition, cabozantinib, pazopanib, regorafenib, and sorafenib were used as controls in the DockingServer program.
Results
The results showed different amino acid residues involved in the interaction of amino-nitrile derivatives with the 3hng protein surface compared with the controls. In addition, the inhibition constant (Ki) was lower for Compounds 10 and 34 than for cabozantinib. Other results show that Ki for Compounds 9, 10, 14, 27–29 and 34–36 was lower in comparison with pazopanib, regorafenib, and sorafenib.
Conclusions
All theoretical data suggest that amino-nitrile derivatives could produce changes in the growth of some cancer cell lines through VEGFR-1 inhibition. Therefore, these amino-nitrile derivatives could be a therapeutic alternative to treat some types of cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Pharmaco-Chemistry, Faculty of Chemical Biological Sciences, University Autonomous of Campeche, Campeche, Camp., México.
- Escuela Nacional de Ciencias Biológicas del Instituto Politécnico Nacional. Santo Tomas, México.
- Facultad de Nutrición, Universidad Veracruzana, Médicos y Odontologos, Unidad del Bosque Xalapa Veracruz, México.
Zitieren
APA
Figueroa-Valverde, L., Díaz-Cedillo, F., Rosas-Nexticapa, M., Alvarez-Ramirez, M., Mateu-Armad, M. V., López-Ramos, M., & López-Gutierrez, T. (2023). Interaction of Some Amino-Nitrile Derivatives with Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) Using a Theoretical Model. Drug Research, 73(06), 355-364. https://doi.org/10.1055/a-2062-3571
Vancouver
Figueroa-Valverde L, Díaz-Cedillo F, Rosas-Nexticapa M, Alvarez-Ramirez M, Mateu-Armad MV, López-Ramos M, et al. Interaction of Some Amino-Nitrile Derivatives with Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) Using a Theoretical Model. Drug Research. 2023;73(06):355-364. doi:10.1055/a-2062-3571
BibTeX
@article{FigueroaValverde2023,
author = {Figueroa-Valverde, Lauro and Díaz-Cedillo, Francisco and Rosas-Nexticapa, Marcela and Alvarez-Ramirez, Magdalena and Mateu-Armad, Maria Virginia and López-Ramos, Maria and López-Gutierrez, Tomas},
title = {Interaction of Some Amino-Nitrile Derivatives with Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) Using a Theoretical Model},
journal = {Drug Research},
year = {2023},
volume = {73},
number = {06},
pages = {355--364},
doi = {10.1055/a-2062-3571}
}
EUVIMED